Thor Industries (THO) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
13 Jun, 2025Executive summary
Fiscal 2024 net sales declined 9.7% year-over-year to $10.04B, with 186,908 unit shipments and a gross profit margin of 14.5%.
Diluted EPS was $4.94, down 28.9% year-over-year, but exceeded recent guidance.
Management emphasized disciplined production, operational efficiency, and strong liquidity to navigate macroeconomic headwinds.
European segment delivered strong net sales and margin, while North American segments faced headwinds.
Financial highlights
Fiscal 2024 net sales were $10.04B, down 9.7% year-over-year; Q4 net sales were $2.53B, down 7.4%.
Gross profit margin improved to 14.5% for the year and 15.8% in Q4.
Diluted EPS was $4.94; Q4 EPS was $1.68.
Cash from operations totaled $545.5M for the year and $338.0M in Q4.
Share repurchases totaled $68.4M for 720,997 shares.
Outlook and guidance
FY2025 net sales expected between $9.0B–$9.8B, with gross margin of 14.7%–15.2%.
Diluted EPS guidance is $4.00–$5.00 for FY2025.
Management expects continued market headwinds in North America and Europe, with discounting to remain elevated in Motorized and moderate in Towable segments.
Expects stronger retail environment in late calendar 2025 and early FY2026.
Latest events from Thor Industries
- Q2 FY26 net sales rose 5.3% to $2.13B, with net income at $17.8M and guidance unchanged.THO
Q2 20263 Mar 2026 - Q1 FY26 saw 11.5% sales growth, margin gains, and a return to profitability.THO
Q1 20263 Dec 2025 - FY2024 saw record European sales, robust governance, and expanded ESG initiatives.THO
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and equity plan on Dec 17, 2025.THO
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor ratification, and executive compensation.THO
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, auditor, executive pay, and a new equity plan amid strong cash flow.THO
Proxy Filing3 Nov 2025 - Solid FY25 results with $9.58B sales, market share gains, and strong cash flow amid restructuring.THO
Q4 202524 Sep 2025 - Net sales fell 14.3% and a net loss was posted, but long-term outlook remains positive.THO
Q1 202513 Jun 2025 - Q3 net sales dropped 4.4% to $2.80B as guidance was cut and European growth outpaced North America.THO
Q3 202413 Jun 2025